glp-1 bowel obstruction attorney in louisiana gastric intestinal GLP-1 Medication Lawyer in Georgia-mvanhaasteren.nl louisiana glp-1 stomach paralysis lawyer
Description
doi: 10.1038/s42255-023-00966-w
The glucagon-like peptide-1 (GLP-1) receptor is a key regulator of glucose homeostasis and a drug target for type 2 diabetes but available GLP-1R agonists are suboptimal due to several side-effects
Why this matters (and dont underestimate it): ~20% weight loss in non-diabetic obesity (REDEFINE-1) 1416% weight loss in T2D (REDEFINE-2) Dual mechanism = appetite suppression + satiety reinforcement Designed for long-term maintenance, not just short-term loss Potentially better GI tolerability with flexible titration This isnt another GLP-1. Its a clear signal that amylin is emerging as a serious second pillar in next-gen obesity care
Triagonists (for example GLP-1/GIP/glucagon) are currently in pre-clinical or early clinical development
Territory Foods is a healthy meal delivery service
